These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2088319)

  • 21. Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.
    Mackinnon S; Hows JM; Goldman JM; Arthur CK; Hughes T; Apperley JF; Jones L; Batchelor JR; Brookes P; Catovsky D
    Exp Hematol; 1990 Jun; 18(5):421-5. PubMed ID: 2338131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
    Bishop MR; Henslee-Downey PJ; Anderson JR; Romond EH; Marciniak E; Yankey R; Reeves M; Thompson JS
    Bone Marrow Transplant; 1996 Oct; 18(4):747-53. PubMed ID: 8899190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect.
    Barrett AJ; Mavroudis D; Tisdale J; Molldrem J; Clave E; Dunbar C; Cottler-Fox M; Phang S; Carter C; Okunnieff P; Young NS; Read EJ
    Bone Marrow Transplant; 1998 Mar; 21(6):543-51. PubMed ID: 9543057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
    Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB).
    Akatsuka Y; Kodera Y; Yamamoto K; Minami S; Miyamura K; Morishita Y; Morishima Y; Saitoh H; Horibe K; Yamauchi T
    Int J Hematol; 1992 Jun; 55(3):249-53. PubMed ID: 1498315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second HLA-identical sibling transplants for leukemia recurrence.
    Mrsíc M; Horowitz MM; Atkinson K; Biggs JC; Champlin RE; Ehninger G; Gajewski JL; Gale RP; Herzig RH; Prentice HG
    Bone Marrow Transplant; 1992 Apr; 9(4):269-75. PubMed ID: 1600415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allogeneic bone marrow transplantation in chronic myeloid leukemia. The results of HLA-identical transplants in the Federal Republic of Germany].
    Schmitz N
    Dtsch Med Wochenschr; 1990 Jun; 115(24):923-9. PubMed ID: 2357928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.
    McGlave P; Bartsch G; Anasetti C; Ash R; Beatty P; Gajewski J; Kernan NA
    Blood; 1993 Jan; 81(2):543-50. PubMed ID: 8422471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone marrow transplantation for chronic myelogenous leukemia].
    Imanari A; Shibata A
    Nihon Rinsho; 1990 Sep; 48(9):2087-91. PubMed ID: 2232214
    [No Abstract]   [Full Text] [Related]  

  • 36. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
    Champlin R; Jansen J; Ho W; Gajewski J; Nimer S; Lee K; Territo M; Winston D; Tricot G; Reichert T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1695-6. PubMed ID: 1899162
    [No Abstract]   [Full Text] [Related]  

  • 37. Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation.
    Thirman MJ; Devine SM; O'Toole K; Cizek G; Jessurun J; Hertz M; Geller RB
    Bone Marrow Transplant; 1992 Sep; 10(3):307-11. PubMed ID: 1422484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Delbaldo C; Rieckhoff-Cantoni L; Helg C; Saurat JH
    Bone Marrow Transplant; 1992 Oct; 10(4):377-9. PubMed ID: 1422495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.
    Kalhs P; Schwarzinger I; Anderson G; Mori M; Clift RA; Storb R; Buckner CD; Appelbaum FR; Hansen JA; Sullivan KM
    Blood; 1995 Sep; 86(5):2028-32. PubMed ID: 7655031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic myeloid leukemia treated by allogeneic bone marrow transplantation.
    Szer J; Sheridan WP
    Transplant Proc; 1992 Feb; 24(1):181-2. PubMed ID: 1539235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.